(SRPT) Sarepta Therapeutics - Performance -88.1% in 12m
SRPT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.90%
#92 in Peer-Group
Rel. Strength
1.46%
#7551 in Stock-Universe
Total Return 12m
-88.10%
#193 in Peer-Group
Total Return 5y
-88.78%
#110 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 9.84 |
| High / Low | USD |
|---|---|
| 52 Week High | 152.67 USD |
| 52 Week Low | 17.10 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 32.06 |
| Buy/Sell Signal +-5 | -2.23 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SRPT (-88.1%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: SRPT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SRPT
| Total Return (including Dividends) | SRPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -49.78% | 4.10% | 4.77% |
| 3 Months | -66.74% | 13.70% | 16.02% |
| 12 Months | -88.10% | -12.86% | 12.44% |
| 5 Years | -88.78% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | SRPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -59.7% | 52.1% | 90.3% |
| 3 Months | -83.2% | 79.4% | 97.5% |
| 12 Months | -94.8% | -87.4% | 46.4% |
| 5 Years | 3.3% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th0.50 | -51.76% | -52.07% |
| 3 Month | %th0.50 | -70.75% | -71.33% |
| 12 Month | %th4.50 | -86.34% | -89.42% |
| 5 Years | %th43.00 | -85.63% | -94.73% |
FAQs
Does Sarepta Therapeutics (SRPT) outperform the market?
No,
over the last 12 months SRPT made -88.10%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months SRPT made -66.74%, while XBI made 13.70%.
Performance Comparison SRPT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SRPT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.4% | -54.6% | -92.6% | -101% |
| US NASDAQ 100 | QQQ | 4.5% | -55.1% | -94.6% | -100% |
| German DAX 40 | DAX | 4.1% | -52.9% | -104.7% | -118% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.3% | -54.9% | -97% | -107% |
| Hongkong Hang Seng | HSI | 3.6% | -53.7% | -114.6% | -122% |
| India NIFTY 50 | INDA | 5.8% | -51.3% | -93% | -85% |
| Brasil Bovespa | EWZ | 8.7% | -49.4% | -107.6% | -89% |
SRPT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.8% | -53.4% | -95.9% | -112% |
| Consumer Discretionary | XLY | 3.5% | -54.6% | -84.9% | -105% |
| Consumer Staples | XLP | 6.5% | -50.3% | -91.6% | -96% |
| Energy | XLE | 1.5% | -51.8% | -85% | -88% |
| Financial | XLF | 5.9% | -54.5% | -94.9% | -111% |
| Health Care | XLV | 4.3% | -49.6% | -81.1% | -81% |
| Industrial | XLI | 4% | -55.4% | -98.4% | -110% |
| Materials | XLB | 3.8% | -55.1% | -93.2% | -91% |
| Real Estate | XLRE | 4.7% | -49.9% | -91.1% | -95% |
| Technology | XLK | 4.6% | -56.9% | -97.7% | -98% |
| Utilities | XLU | 4.4% | -51.8% | -96.6% | -110% |
| Aerospace & Defense | XAR | 3.8% | -57% | -112.6% | -135% |
| Biotech | XBI | 0.8% | -53.9% | -82.3% | -75% |
| Homebuilder | XHB | 1.4% | -61.1% | -86% | -85% |
| Retail | XRT | 4.5% | -56.6% | -87.7% | -95% |
SRPT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.9% | -46.1% | -78.7% | -85% |
| Natural Gas | UNG | 6.2% | -41% | -66.6% | -91% |
| Gold | GLD | 4.3% | -47.5% | -110.5% | -126% |
| Silver | SLV | 0.1% | -56% | -114.6% | -113% |
| Copper | CPER | -5.9% | -65.7% | -112.1% | -111% |
SRPT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.3% | -49.5% | -87.3% | -84% |
| iShares High Yield Corp. Bond | HYG | 5% | -51.1% | -89.6% | -97% |